Published in Neurology on August 27, 2002
Electrical Brain Stimulation to Reduce Epileptic Seizures | NCT00344877
Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol (2009) 11.59
Therapeutic devices for epilepsy. Ann Neurol (2012) 1.50
Safety and tolerability of repetitive transcranial magnetic stimulation in patients with pathologic positive sensory phenomena: a review of literature. Brain Stimul (2011) 1.47
Technology insight: neuroengineering and epilepsy-designing devices for seizure control. Nat Clin Pract Neurol (2008) 1.28
Noninvasive techniques for probing neurocircuitry and treating illness: vagus nerve stimulation (VNS), transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS). Neuropsychopharmacology (2010) 1.25
Noninvasive brain stimulation protocols in the treatment of epilepsy: current state and perspectives. Neurotherapeutics (2009) 1.25
Transcranial magnetic stimulation in child neurology: current and future directions. J Child Neurol (2007) 1.16
Transcranial brain stimulation: clinical applications and future directions. Neurosurg Clin N Am (2011) 1.00
Transcranial Magnetic Stimulation in Epilepsy. Epilepsy Curr (2003) 0.99
NON-INVASIVE BRAIN STIMULATION IN CHILDREN: APPLICATIONS AND FUTURE DIRECTIONS. Transl Neurosci (2013) 0.95
The therapeutic potential of focal cooling for neocortical epilepsy. Neurotherapeutics (2009) 0.92
Toward a noninvasive automatic seizure control system in rats with transcranial focal stimulations via tripolar concentric ring electrodes. IEEE Trans Neural Syst Rehabil Eng (2012) 0.89
Permutation entropy to detect vigilance changes and preictal states from scalp EEG in epileptic patients. A preliminary study. Neurol Sci (2008) 0.89
A review of traditional and novel treatments for seizures in autism spectrum disorder: findings from a systematic review and expert panel. Front Public Health (2013) 0.88
Seizure suppression by EEG-guided repetitive transcranial magnetic stimulation in the rat. Clin Neurophysiol (2008) 0.88
An estimate of placebo effect of repetitive transcranial magnetic stimulation in epilepsy. Epilepsy Behav (2011) 0.85
Improvement of health-related quality of life in depression after transcranial magnetic stimulation in a naturalistic trial is associated with decreased perfusion in precuneus. Health Qual Life Outcomes (2012) 0.84
Cortico-cortical modulation induced by 1-Hz repetitive transcranial magnetic stimulation of the temporal cortex. J Clin Neurol (2013) 0.83
Experimental Electrical Stimulation Therapy for Epilepsy. Curr Treat Options Neurol (2005) 0.82
Effects of transcranial focal electrical stimulation via tripolar concentric ring electrodes on pentylenetetrazole-induced seizures in rats. Epilepsy Res (2013) 0.81
Enhancement of Neuromodulation with Novel Pulse Shapes Generated by Controllable Pulse Parameter Transcranial Magnetic Stimulation. Brain Stimul (2015) 0.81
Noninvasive transcranial focal stimulation via tripolar concentric ring electrodes lessens behavioral seizure activity of recurrent pentylenetetrazole administrations in rats. IEEE Trans Neural Syst Rehabil Eng (2012) 0.80
Neuromodulation and Transcranial Mag Netic Stimulation (TMS): A 21st Century Paradigm for Therapeutics in Psychiatry. Psychiatry (Edgmont) (2006) 0.80
Immediate Effects of Repetitive Magnetic Stimulation on Single Cortical Pyramidal Neurons. PLoS One (2017) 0.80
Commentary: physical approaches for the treatment of epilepsy: electrical and magnetic stimulation and cooling. Neurotherapeutics (2009) 0.79
In-session seizures during low-frequency repetitive transcranial magnetic stimulation in patients with epilepsy. Epilepsy Behav (2009) 0.78
Effects of repetitive transcranial magnetic stimulation in a patient with fixation-off sensitivity. Exp Brain Res (2006) 0.77
Effect of different frequencies of repetitive transcranial magnetic stimulation on acquisition of chemical kindled seizures in rats. Neurol Sci (2013) 0.77
Low- vs High-Frequency Repetitive Transcranial Magnetic Stimulation as an Add-On Treatment for Refractory Depression. Front Psychiatry (2012) 0.77
Repetitive transcranial magnetic stimulation in psychiatry. Ann Indian Acad Neurol (2011) 0.76
Are the effects of stimulation catching? Epilepsy Curr (2005) 0.75
Epilepsy: The future scenario. Ann Indian Acad Neurol (2010) 0.75
New developments in the management of partial-onset epilepsy: role of brivaracetam. Drug Des Devel Ther (2017) 0.75
History, Studies and Specific Uses of Repetitive Transcranial Magnetic Stimulation (rTMS) in Treating Epilepsy. Iran J Child Neurol (2016) 0.75
Clinical application of TMS to epilepsy. J Epilepsy Res (2012) 0.75
H-coil repetitive transcranial magnetic stimulation for treatment of temporal lobe epilepsy: A case report. Epilepsy Behav Case Rep (2016) 0.75
TMS: A Tailored Method of Stimulation for Refractory Focal Epilepsy? Epilepsy Curr (2013) 0.75
Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member. Cell (1992) 12.74
UMLS concept indexing for production databases: a feasibility study. J Am Med Inform Assoc (2001) 9.02
Organization of heterogeneous scientific data using the EAV/CR representation. J Am Med Inform Assoc (1999) 6.97
Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: a cohort study. Lancet (2001) 6.67
Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice. Science (1993) 5.50
Dynamic proteomics of individual cancer cells in response to a drug. Science (2008) 5.43
Randomised trial of laparoscopic exploration of common bile duct versus postoperative endoscopic retrograde cholangiography for common bile duct stones. Lancet (1998) 5.10
Cerebral mechanisms of word masking and unconscious repetition priming. Nat Neurosci (2001) 5.07
Are children's hospitals an idea whose time has come and gone? CMAJ (1993) 4.70
Hospital foundations raise large amounts of money, but also raise some troublesome issues. CMAJ (1993) 4.60
Water diffusion changes in Wallerian degeneration and their dependence on white matter architecture. Neuroimage (2001) 4.48
GEM: a proposal for a more comprehensive guideline document model using XML. J Am Med Inform Assoc (2000) 4.46
Infectivity, transmission, and pathology of human-isolated H7N9 influenza virus in ferrets and pigs. Science (2013) 4.17
Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha. J Immunol (1999) 3.99
Should nurse practitioners play a larger role in Canada's health care system? CMAJ (1992) 3.41
Randomized clinical trial of early laparoscopy in the management of acute non-specific abdominal pain. Br J Surg (1999) 3.18
Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron (1998) 3.08
Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide. Leukemia (2012) 3.04
Cerebral pathways for calculation: double dissociation between rote verbal and quantitative knowledge of arithmetic. Cortex (1997) 2.64
Primary structure of major outer membrane protein II (ompA protein) of Escherichia coli K-12. Proc Natl Acad Sci U S A (1980) 2.64
Primary structure of major outer membrane protein I of Escherichia coli B/r. Proc Natl Acad Sci U S A (1979) 2.60
The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster. Immunity (1994) 2.59
The hemodynamic and adrenergic effects of perioperative dexmedetomidine infusion after vascular surgery. Anesth Analg (2000) 2.56
Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment. Cell Death Dis (2013) 2.52
Lewy bodies and parkinsonism in families with parkin mutations. Ann Neurol (2001) 2.50
Synergism between subpopulations of thymus-derived cells mediating the proliferative and effector phases of the mixed lymphocyte reaction. Proc Natl Acad Sci U S A (1973) 2.48
Controlled-drinking advocates challenge use of abstinence model in treatment of addiction. CMAJ (1993) 2.41
Letter binding and invariant recognition of masked words: behavioral and neuroimaging evidence. Psychol Sci (2004) 2.41
Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member. Cell (1992) 2.38
The Ottawa Heart Institute: it's good, but can we afford it? CMAJ (1990) 2.35
Mirror movements in parkinsonism: evaluation of a new clinical sign. J Neurol Neurosurg Psychiatry (2005) 2.35
A randomized trial of varenicline (Chantix) for the treatment of spinocerebellar ataxia type 3. Neurology (2012) 2.34
Abstract representations of numbers in the animal and human brain. Trends Neurosci (1998) 2.31
The mental representation of hand movements after parietal cortex damage. Science (1996) 2.28
Receptors for polytropic and xenotropic mouse leukaemia viruses encoded by a single gene at Rmc1. Nat Genet (1999) 2.28
Lower BMI cut-off value to define obesity in Hong Kong Chinese: an analysis based on body fat assessment by bioelectrical impedance. Br J Nutr (2001) 2.25
A peripheral blood diagnostic test for acute rejection in renal transplantation. Am J Transplant (2012) 2.25
Simultaneous measurement of six cytokines in a single sample of human tears using microparticle-based flow cytometry: allergics vs. non-allergics. J Immunol Methods (2001) 2.22
Evidence of limited variability of antigen receptors on intrathyroidal T cells in autoimmune thyroid disease. N Engl J Med (1991) 2.21
Saxagliptin given in combination with metformin as initial therapy improves glycaemic control in patients with type 2 diabetes compared with either monotherapy: a randomized controlled trial. Diabetes Obes Metab (2009) 2.19
Subthalamic deep brain stimulation at individualized frequencies for Parkinson disease. Neurology (2012) 2.18
Short-term effectiveness of anticipatory guidance to reduce early childhood risks for subsequent violence. Arch Pediatr Adolesc Med (1997) 2.15
Pharmacologic management of psychiatric illness during pregnancy: dilemmas and guidelines. Am J Psychiatry (1996) 2.14
Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary. Proc Natl Acad Sci U S A (1994) 2.14
Simultaneous bilateral laser in situ keratomileusis: safety and efficacy. Ophthalmology (1999) 2.13
Influence of pH on vaginal discharges. Br J Vener Dis (1969) 2.12
The cortical representation of speech. J Cogn Neurosci (1993) 2.12
The safety of acellular pertussis vaccine vs whole-cell pertussis vaccine. A postmarketing assessment. Arch Pediatr Adolesc Med (1996) 2.11
Altered glucose metabolism in microvessels from patients with Alzheimer's disease. Ann Neurol (1989) 2.08
The impact of pre-hospital thrombolytic treatment on re-infarction rates: analysis of the Myocardial Infarction National Audit Project (MINAP). Heart (2007) 2.06
Complete amino acid sequence and glycosylation sites of glycoprotein gp71A of Friend murine leukemia virus. Proc Natl Acad Sci U S A (1982) 2.06
Can physicians afford not to get involved in hospital administration? CMAJ (1992) 2.03
Novel thalidomide analogues display anti-angiogenic activity independently of immunomodulatory effects. Br J Cancer (2002) 2.03
Theaflavins in black tea and catechins in green tea are equally effective antioxidants. J Nutr (2001) 2.02
Breaking bad news about cancer: patients' preferences for communication. J Clin Oncol (2001) 2.00
Differential contributions of the left and right inferior parietal lobules to number processing. J Cogn Neurosci (1999) 1.98
Transformation of group F streptococci by plasmid DNA. J Gen Microbiol (1978) 1.97
DNA-dependent protein kinase stimulates an independently active, nonhomologous, end-joining apparatus. Cancer Res (2000) 1.97
Radioimmunological screening method for specific membrane proteins. Anal Biochem (1979) 1.96
Physical and psychological morbidity after axillary lymph node dissection for breast cancer. J Clin Oncol (1999) 1.96
'Alternative cancer cures': looking for common ground. Lancet Oncol (2000) 1.95
Methods utilizing cell-free protein-synthesizing systems for the identification of recombinant DNA molecules. Methods Enzymol (1983) 1.94
Interactions between two different inhibitory systems in the human motor cortex. J Physiol (2001) 1.91
Induction of human interferon gene expression is associated with a nuclear factor that interacts with the NF-kappa B site of the human immunodeficiency virus enhancer. J Virol (1989) 1.90
An apoptosis-inducing genotoxin differentiates heterozygotic carriers for Werner helicase mutations from wild-type and homozygous mutants. Hum Genet (1997) 1.88
Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart. Proc Natl Acad Sci U S A (1995) 1.86
A force-plate actometer for quantitating rodent behaviors: illustrative data on locomotion, rotation, spatial patterning, stereotypies, and tremor. J Neurosci Methods (2001) 1.86
Individual differences in allocation of funds in the dictator game associated with length of the arginine vasopressin 1a receptor RS3 promoter region and correlation between RS3 length and hippocampal mRNA. Genes Brain Behav (2007) 1.86
Cloning and functional expression of a rat brain corticotropin releasing factor (CRF) receptor. Endocrinology (1993) 1.83
TWISTing stemness, inflammation and proliferation of epithelial ovarian cancer cells through MIR199A2/214. Oncogene (2010) 1.81
Risk of chronic arthropathy among women after rubella vaccination. Vaccine Safety Datalink Team. JAMA (1997) 1.78
MMR2 immunization at 4 to 5 years and 10 to 12 years of age: a comparison of adverse clinical events after immunization in the Vaccine Safety Datalink project. The Vaccine Safety Datalink Team. Pediatrics (1997) 1.77
Anatomical variability in the cortical representation of first and second language. Neuroreport (1997) 1.74
Low serum cholesterol and mortality. Which is the cause and which is the effect? Circulation (1995) 1.73
Complications of laparoscopic procedures after concentrated training in urological laparoscopy. J Urol (2001) 1.71
Randomized, blind, controlled trial of transdermal rotigotine in early Parkinson disease. Neurology (2007) 1.68
Adeno-associated virus-mediated gene transfer to the brain: duration and modulation of expression. Hum Gene Ther (1999) 1.67
Lipid composition of Saccharomyces cerevisiae as influenced by growth temperature. Biochim Biophys Acta (1972) 1.66
Dextromethorphan decreases the excitability of the human motor cortex. Neurology (1998) 1.66
Effects of low-frequency transcranial magnetic stimulation on motor excitability and basic motor behavior. Clin Neurophysiol (2000) 1.63
Understanding dissociations in dyscalculia: a brain imaging study of the impact of number size on the cerebral networks for exact and approximate calculation. Brain (2000) 1.63
Amino-substituted thalidomide analogs: potent inhibitors of TNF-alpha production. Bioorg Med Chem Lett (1999) 1.62
Effect of saxagliptin monotherapy in treatment-naïve patients with type 2 diabetes. Curr Med Res Opin (2009) 1.62
Complete surgical excision is effective treatment for children with immature teratomas with or without malignant elements: A Pediatric Oncology Group/Children's Cancer Group Intergroup Study. J Clin Oncol (1999) 1.61
A clone-array pooled shotgun strategy for sequencing large genomes. Genome Res (2001) 1.60
Determining the cost of genital warts: a study from Ireland. Sex Transm Infect (2008) 1.60
Involvement of the human pedunculopontine nucleus region in voluntary movements. Neurology (2010) 1.60
Involvement of the human subthalamic nucleus in movement preparation. Neurology (2003) 1.59
Intracellular Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in buccal epithelial cells collected from human subjects. Infect Immun (2001) 1.58
Role of the human motor cortex in rapid motor learning. Exp Brain Res (2001) 1.58
The pharmacology of bimatoprost (Lumigan). Surv Ophthalmol (2001) 1.54
Farnesyl pyrophosphate synthase is the molecular target of nitrogen-containing bisphosphonates. Biochem Biophys Res Commun (1999) 1.54
Nucleotide sequence of the gene for the peptidoglycan-associated lipoprotein of Escherichia coli K12. Eur J Biochem (1987) 1.53
Antibacterial agents that inhibit two-component signal transduction systems. Proc Natl Acad Sci U S A (1998) 1.53
Renal denervation attenuates the sodium retention and hypertension associated with obesity. Hypertension (1995) 1.53
The primary structure of protein L16 located at the peptidyltransferase center of Escherichia coli ribosomes. FEBS Lett (1976) 1.53
Inflammatory pseudotumor of the liver. Report of the fine needle aspiration cytologic findings in a case initially misdiagnosed as malignant. Acta Cytol (1989) 1.51
Root gravitropism: an experimental tool to investigate basic cellular and molecular processes underlying mechanosensing and signal transmission in plants. Annu Rev Plant Biol (2002) 1.51